Cargando…

Cost-Effectiveness of Antiretroviral Therapy for Prevention

Recent empirical studies and analyses have heightened interest in the use of expanded antiretroviral therapy (ART) for prevention of HIV transmission. However, ART is expensive, approximately $600 per person per year, raising issues of the cost and cost-effectiveness of ambitious ART expansion. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kahn, James G, Marseille, Elliot A, Bennett, Rod, Williams, Brian G, Granich, Reuben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529401/ https://www.ncbi.nlm.nih.gov/pubmed/21999776 http://dx.doi.org/10.2174/157016211798038542

Ejemplares similares

Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis
por: Granich, Reuben, et al.
Publicado: (2011)

Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia
por: Marseille, Elliot, et al.
Publicado: (2012)

Cost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting
por: Kahn, James G, et al.
Publicado: (2006)

Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health
por: Marseille, Elliot, et al.
Publicado: (2019)

Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries
por: Marseille, Elliot, et al.
Publicado: (2014)

Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study
por: Marseille, Elliot A, et al.
Publicado: (2011)

Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial
por: Marseille, Elliot, et al.
Publicado: (2022)

CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
por: Kahn, James G, et al.
Publicado: (2011)

Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050
por: Granich, Reuben, et al.
Publicado: (2012)

Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial
por: Marseille, Elliot, et al.
Publicado: (2022)

The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study
por: Avanceña, Anton L. V., et al.
Publicado: (2022)

Thresholds for the cost–effectiveness of interventions: alternative approaches
por: Marseille, Elliot, et al.
Publicado: (2015)

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020)

Circumcision for HIV Prevention: Authors' Reply
por: Kahn, James G, et al.
Publicado: (2007)

Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
por: Suthar, Amitabh B., et al.
Publicado: (2012)

Highly active antiretroviral treatment for the prevention of HIV transmission
por: Granich, Reuben, et al.
Publicado: (2010)

Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda
por: Jain, Vivek, et al.
Publicado: (2015)

Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis
por: Kortz, Teresa Bleakly, et al.
Publicado: (2017)

The Potential Impact of Expanding Antiretroviral Therapy and Combination Prevention in Vietnam: Towards Elimination of HIV Transmission
por: Kato, Masaya, et al.
Publicado: (2013)

Antiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts
por: Granich, Reuben, et al.
Publicado: (2011)

The economics of psychedelic-assisted therapies: A research agenda
por: Marseille, Elliot, et al.
Publicado: (2022)

Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting
por: Koethe, John R, et al.
Publicado: (2014)

Adult male circumcision in Nyanza, Kenya at scale: the cost and efficiency of alternative service delivery modes
por: Marseille, Elliot, et al.
Publicado: (2014)

Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India
por: Dandona, Lalit, et al.
Publicado: (2008)

Achieving Universal Access for Human Immunodeficiency Virus and Tuberculosis: Potential Prevention Impact of an Integrated Multi-Disease Prevention Campaign in Kenya
por: Granich, Reuben, et al.
Publicado: (2012)

Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya?
por: Verguet, Stéphane, et al.
Publicado: (2015)

A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact
por: Marseille, Elliot, et al.
Publicado: (2016)

Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis
por: Maya, Sigal, et al.
Publicado: (2021)

Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis
por: Maya, Sigal, et al.
Publicado: (2022)

HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency
por: Dandona, Lalit, et al.
Publicado: (2005)

Questionable assumptions mar modelling of Kenya home‐based testing campaigns
por: Granich, Reuben, et al.
Publicado: (2019)

HIV, 95‐95‐95 and the allocative efficiency fallacy: why treating everyone makes sense from a humanitarian, clinical, economic and disease control perspective
por: Granich, Reuben, et al.
Publicado: (2018)

Population uptake and effectiveness of test‐and‐treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross‐national analysis
por: Mendez‐Lopez, A, et al.
Publicado: (2019)

Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach
por: Jiwani, Aliya, et al.
Publicado: (2014)

Cost-effectiveness analyses of training: a manager’s guide
por: O’Malley, Gabrielle, et al.
Publicado: (2013)

Costing Human Rights and Community Support Interventions as a Part of Universal Access to HIV Treatment and Care in a Southern African Setting
por: Jones, Louisa, et al.
Publicado: (2011)

Estimating the Resources Needed and Savings Anticipated from Roll-Out of Adult Male Circumcision in Sub-Saharan Africa
por: Auvert, Bertran, et al.
Publicado: (2008)

Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India
por: Dandona, Lalit, et al.
Publicado: (2005)

Is Antiretroviral Therapy Cost-Effective in South Africa?
por: Braithwaite, R. Scott, et al.
Publicado: (2006)

The cost of antiretroviral therapy in Haiti
por: Koenig, Serena P, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ardhfc36criqcrggah9gd0ac2t